ATHENS, Texas, Nov. 16, 2010 /PRNewswire/ -- Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with Rex Medical, LP ("Rex Medical") for exclusive rights to market and distribute the UltraStream chronic dialysis catheter ™ on a global basis. UltraStream™ is designed to provide long-term vascular access to patients receiving dialysis treatments.
Argon will be exhibiting at the 37th Veithsymposium™ to be held in New York City from November 17-21, 2010.
"The addition of UltraStream™ reinforces our commitment to providing physicians with innovative products focused on improving patient care," said George A. Leondis, President of Argon Medical Devices, Inc. "We are excited about this opportunity to further enhance our portfolio of products for use in the area of dialysis access, which also includes the Cleaner™ Rotational Thrombectomy System."
There are over 500,000 patients currently undergoing treatment in the U.S. for End-Stage Renal Disease (ESRD). It is estimated that the dialysis patient population will continue to grow at a rate exceeding 6% annually.
Argon Medical Devices, Inc., based in Athens, TX, is a privately-held global medical device company which manufactures and markets solutions for cardiovascular, venous access and critical care procedures. It is a portfolio company of Roundtable Healthcare Partners.
RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the health-care industry. The partners of RoundTable have significant experience in managing, operating, acquiring and financing multibillion-dollar diversified health-care companies. RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.
About Rex Medical